Citation Impact
Citing Papers
Shortened bleeding time in acute myocardial infarction and its relation to platelet mass.
1985
Static platelet adhesion, flow cytometry and serum TXB2 levels for monitoring platelet inhibiting treatment with ASA and clopidogrel in coronary artery disease: a randomised cross-over study
2009 StandoutNobel
Child abuse: Adolescent records vs. adult recall
1990 Standout
Cardiac rupture, mortality and the timing of thrombolytic therapy: A meta-analysis
1990
Omega-3 fatty acids in health and disease and in growth and development
1991 Standout
SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials
2013 Standout
Platelets and acute cerebral infarction
2012 StandoutNobel
Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival
2003 Standout
Cumulating evidence from randomized trials: Utilizing sequential monitoring boundaries for cumulative meta-analysis
1997
Mechanisms of neurotransmitter release by amphetamines: A review
2005 Standout
Global nutrition transition and the pandemic of obesity in developing countries
2012 Standout
Mean platelet volume (MPV) increase during acute non-lacunar ischemic strokes
2008
Blood pressure and socioeconomic status in low-income women in Mexico: a reverse gradient?
2008
GRADE guidelines 6. Rating the quality of evidence—imprecision
2011 Standout
Frequency of acute coronary syndrome in patients presenting to the Emergency Department with chest pain after methamphetamine use
2003
Randomized, Controlled Trials, Observational Studies, and the Hierarchy of Research Designs
2000 Standout
Exercise-based cardiac rehabilitation for coronary heart disease
2011 Standout
Antithrombotic Therapy for Venous Thromboembolic Disease
2001 Standout
Systematic Review of the Influence of Childhood Socioeconomic Circumstances on Risk for Cardiovascular Disease in Adulthood
2005
Early Enteral Feeding, Compared With Parenteral, Reduces Postoperative Septic Complications The Results of a Meta-Analysis
1992 Standout
CONSORT 2010 explanation and elaboration: Updated guidelines for reporting parallel group randomised trials
2011 Standout
Plants and the central nervous system
2003 Standout
Evaluating the evidence for models of life course socioeconomic factors and cardiovascular outcomes: a systematic review
2005
Risk factors for pre-eclampsia at antenatal booking: systematic review of controlled studies
2005 Standout
Antithrombotic Therapy for Venous Thromboembolic Disease
2004 Standout
The causal role of megakaryocyte–platelet hyperactivity in acute coronary syndromes
2012
Advances in Thrombolytic Therapy
1982
Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients
1994 Standout
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
2019 Standout
Plasminogen Activators, Tissue Degradation, and Cancer
1985 Standout
Coronary Thrombolysis for Evolving Myocardial Infarction
1984
Mechanisms of Plaque Formation and Rupture
2014 Standout
Meta‐analysis of clinical trials as a scientific discipline. I: Control of bias and comparison with large co‐operative trials
1987
Intracoronary infusion of streptokinase in patients with acute myocardial infarction: Effects of reperfusion on left ventricular performance
1981
Khat: pharmacological and medical aspects and its social use in Yemen
2002
Qualitative and quantitative changes in platelets after coronary-artery bypass surgery may help identify thrombotic complications and infections
1989
High-dose, brief intravenous streptokinase early in acute myocardial infarction
1982
Echocardiographic examination of the left ventricle.
1975
Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method.
1977 Standout
The Use of Thrombolytic Agents: Choice of Patient, Drug Administration, Laboratory Monitoring
1979
The Revised CONSORT Statement for Reporting Randomized Trials: Explanation and Elaboration
2001 Standout
EFFECTIVENESS OF INTRAVENOUS THROMBOLYTIC TREATMENT IN ACUTE MYOCARDIAL INFARCTION
1986 Standout
2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes
2014 Standout
Reported Methodologic Quality and Discrepancies between Large and Small Randomized Trials in Meta-Analyses
2001 Standout
Effect of Intravenous Streptokinase on Acute Myocardial Infarction
1982
CONSORT 2010 Explanation and Elaboration: updated guidelines for reporting parallel group randomised trials
2010 Standout
Complexity and contradiction in clinical trial research
1987
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
2019 Standout
In-Hospital Exercise after Myocardial Infarction Does Not Improve Treadmill Performance
1981
Meta-analysis in clinical trials
1986 Standout
Plaque fissuring--the cause of acute myocardial infarction, sudden ischaemic death, and crescendo angina.
1985 Standout
Works of P Carson being referenced
Platelet size in myocardial infarction.
1983
Streptokinase in acute myocardial infarction: a controlled multicentre study in the United Kingdom.
1976
Results of Early Mobilization and Discharge after Myocardial Infarction
1973
Left Ventricular Wall Movement in Heart Failure
1971
Childhood risk factors for ischaemic heart disease and stroke
1990
Myocardial infarction due to amphetamine.
1987